Key facts
- Therify’s last known valuation is $8.0M (Aug 2023).
- It has raised $3.4M; the latest was Later Stage VC ($250K) in Jan 2026.
- Notable investors include Y Combinator, SoftBank Group, Launch Tennessee, InvestTN, Alt Capital (San Francisco) — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Therify
- ·The full record, as it builds
Funding rounds
No funding rounds for Therify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Therify
Developer of mental healthcare software designed for the well-being of the workforce. The company's software leverages artificial intelligence (AI) technology to match employees with inclusive, evidence-based mental healthcare, including personalized therapist matching, live community sessions, and digital content, enabling employees to develop skills to experience happiness, productivity, and emotional well-being.
- Sector
- Healthcare
- HQ
- Jersey City, NJ, United States
- Founded
- 2020
- Employees
- 7
- Website
- therify.co/
- Ownership
- Privately Held (backing)
Therify doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Therify shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Therify in its N-PORT filings yet. We sweep new filings monthly.